<SEC-DOCUMENT>0001104659-20-056351-index.html : 20200504
<SEC-HEADER>0001104659-20-056351.hdr.sgml : 20200504
<ACCEPTANCE-DATETIME>20200504183209
ACCESSION NUMBER:		0001104659-20-056351
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20200430
FILED AS OF DATE:		20200504
DATE AS OF CHANGE:		20200504

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Schranz Jennifer
		CENTRAL INDEX KEY:			0001735382

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37558
		FILM NUMBER:		20846309

	MAIL ADDRESS:	
		STREET 1:		1000 CONTINENTAL DRIVE
		STREET 2:		SUITE 600
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nabriva Therapeutics plc
		CENTRAL INDEX KEY:			0001641640
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L2
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		56 FITZWILLIAM SQUARE
		CITY:			DUBLIN
		STATE:			L2
		ZIP:			2
		BUSINESS PHONE:		(610) 816-6640

	MAIL ADDRESS:	
		STREET 1:		1000 CONTINENTAL DRIVE
		STREET 2:		SUITE 600
		CITY:			KING OF PRUSSIA
		STATE:			PA
		ZIP:			19406

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Nabriva Therapeutics AG
		DATE OF NAME CHANGE:	20150507
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>a4.xml
<DESCRIPTION>4
<TEXT>
Document 1 - file: a4.html

Document 1 - RAW XML: a4.xml

</DOCUMENT>
</SEC-DOCUMENT>